Cost-Effectiveness of a Smoking Cessation Program Implemented at the Time of Surgery for Lung Cancer

摘要: Background Many patients are active smokers at the time of a diagnosis surgically resectable lung cancer. Perioperative smoking cessation is associated with improved survival, but cost-effectiveness program initiated immediately before surgery unknown. Methods We developed decision analytic Markov model to evaluate incremental formal program. The parameter estimates were taken from available literature. included cost and effectiveness program, incidence perioperative complications, postoperative mortality, utility measured in quality adjusted life years (QALY). Dollars per QALY year calculated one-way sensitivity analyses performed. Results cost/QALY cost/life $16,415 $45,629 1 after $2609 $2703 5 years, respectively. Most showed postsurgery less than $50,000, all $12,000 years. Cost-effectiveness most sensitive frequency complications estimated short-term estimates. Conclusion A surgical resection cost-effective both postsurgery. Providers should encourage who still engage programs.